Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

psychiatric diseases

- PMLiVE

Extension for head of Germany’s VFA

Birgit Fischer to remain as chief executive of pharma trade body until 2019          

- PMLiVE

Novartis launches another localised NHS eye service in UK

Will provide specialised care to people of Coventry

- PMLiVE

Boehringer drug approved in EU for rare lung disease

Nintedanib is already available as cancer treatment

- PMLiVE

Boehringer partners with US universities

Will work with Yale and Vanderbilt on cancer projects

- PMLiVE

AZ signs yet another cancer immunotherapy deal

Will work with Omnis to develop viruses that target tumour cells

Deal Watch table for December 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

Pharma deals during December 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

NICE recommends Pradaxa in blood clot indication

Boehringer drug backed to treat and prevent deep vein thrombosis and pulmonary embolism

- PMLiVE

ASH: Pradaxa antidote effective in key patient groups

Boehringer posts positive data on use of idarucizumab in elderly and people with kidney impairment

Pharma deals during November 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for November 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Campaigns recognised at German health comms awards

Schmittgall, Pink Carrots and S&H among the winners

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links